Audititi Zinka, Amdocs and REE at a low: news from the Israelis on Wall Street

There was no trading on Wall Street on Friday due to Juneteenth, the holiday that ended slavery in the US. On Thursday, trading closed higher in the leading indices, with the Dow Jones rising 0.1%, the S&P 500 gaining 1.1% and the Nasdaq climbing 1.9%.

These are the Israeli stocks (or those with ties to Israel) that stood out in trading:

Auditi Tech’s stock has jumped and is moving away from the lows

stock Auditi Tech It jumped by 19.1% on Thursday, without any report from the company. At the end of the trading week, the stock closed at a price above $13, for the first time since the beginning of the month. Recall that the company published reports for the first quarter on June 1 and its stock fell to a low, from which it recovered and rose by 32.8%. At the same time, it has not yet returned to the levels at which it traded before the publication of the previous reports in February and certainly not to the peak at which it traded last year – the share price is currently 55% lower than the price in February and 83.1% lower than the peak of June 2025.

Oditi Tech, under the management of Oren Holtzman, is a technology company for the world of beauty, which owns, among other things, the make-up brand Ill Makeup. In recent months, the company has been suffering from a significant disruption at its main advertising partner (Instagram), when an algorithm change led to a sharp increase in customer acquisition costs and significant damage to the company’s results.

The increase in the stock on Thursday was in a small trading cycle compared to the average, and after the increase, the market value of Oditi stands at 603 million dollars. According to Wall Street Journal data, there are currently 11 bodies covering the stock, most of them (8) neutral and the rest negative. Their target prices range from $8-15 – that is, from a discount of about 39% to a premium of about 15% over the current price on the Nasdaq.

Amdocs is at a low of over 6 years, the analysts are optimistic

stock Amdox On Thursday, it weakened by 6.3%, reaching a low of over 6 years, when in fact it returns to the share price at which it was traded at the beginning of the corona epidemic. Since the peak recorded three years ago (when the share price approached $100), Amdocs shares have lost 47.9%. At the end of the week, the stock closed at a price that reflects the company’s market value of approximately 5.5 billion dollars.

Amdocs, managed by Shemai Hurtig who recently took office, provides solutions for telecom and media companies. The company recently launched an extensive round of layoffs of about 10% of its workforce, including, according to estimates, hundreds of employees in Israel. Amdox

Last week, no report was published by the company that could explain the weakness. The investor website Seeking Alpha writes about the company as having opportunities in the field of AI that are not yet reflected in value, and that the decline in the stock (at a rate of about 40% in the past year) limits the additional downside. The investor website Simply Wall Street stated that according to technical analysis there are signs that point to a sale, while analysts who cover Amdocs point to positive data.

Wall Street Journal data shows that out of 7 bodies that cover Amdocs, there are 5 positive, 1 neutral and 1 negative, and their average target price is 64.5% higher than the price on Nasdaq.

REE stock is at an all-time low after falling 33.7% on Thursday

The Autotec company REEwhich started trading on Wall Street less than five years ago at a value of 3.1 billion dollars, reached a low of less than 7 million dollars last weekend. The company’s stock fell by 33.7% on Thursday in a larger than average trading cycle (but partially recovered in late trading).

The company, under the management of co-founder Daniel Barel, is developing a platform for drivetrains for electric vehicles. Last year, it added to its reports a “going concern” note, according to which there is substantial doubt about its ability to continue operating as a going concern in the following 12 months. At the end of 2025, it warned that without new funding, the money would only last until the second quarter of 2026. The “going concern” note was also attached to the 2025 reports published last month. In 2025, the company recorded a net loss of $55.8 million, a reduction compared to a loss of nearly $112 million in 2024 following an efficiency plan, but the company “burned” a similar amount of cash as in 2024, approximately $68.7 million. As of the beginning of last May, the company had cash in the amount of 4.9 million dollars in the coffers. REE reported at the time that it continues to examine measures to maintain liquidity and maximize shareholder value, including a further reduction of costs and various strategic options (when such wording usually means an attempt to sell the company).

Last week, no company reports were published, with the exception of a report that an executive in the company sold shares in a modest amount of about $4,000. The shares were sold on Monday at an average price of about 42 cents, while on Thursday the share price was only 23 cents.

For your attention: The Globes system strives for a diverse, relevant and respectful discourse in accordance with the code of ethics that appears in the trust report according to which we operate. Expressions of violence, racism, incitement or any other inappropriate discourse are filtered out automatically and will not be published on the site.

By Editor